Efficacy and Safety of Adding Alisporivir (DEB025) to Peginterferon (IFN) Alfa-2a (Peg-IFN Alfa-2a) and Ribavirin in Chronic HCV Genotype 1 Patients Who Relapsed or Did Not Respond to Previous Treatment
Clinical trial NCT01183169 · COMPLETED
Trial details
- NCT number
- NCT01183169
- Sponsor
- Debiopharm International SA
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2010-08-01
- Primary completion
- 2013-05-01
- Enrollment
- 459
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.